The Lancet Respiratory Medicine

SJR Rank #146H-index: 212SJR: 7.652Best quartile: Q1APC: US$7,280

Journal website: aims, scope and author guidelines

Publisher

Elsevier Ltd

Country

United Kingdom

Type

journal

SJR by Edition

Subject Categories

Pulmonary and Respiratory MedicineQ1

Areas: Medicine

Most published research topics

Chronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesRespiratory Support and MechanismsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisNeonatal Respiratory Health ResearchCOVID-19 Clinical Research StudiesCystic Fibrosis Research AdvancesTuberculosis Research and EpidemiologyRespiratory and Cough-Related ResearchRespiratory viral infections research

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

2213-2619, 2213-2600

SJR Best Quartile

Region

Western Europe

Citations per Document (2 years)

9.42

References per Document

20.84

Coverage

2013-2026

Scope

The Lancet Respiratory Medicine launched in March 2013 as the fourth Lancet specialty journal following in the footsteps of The Lancet Oncology, The Lancet Neurology, and The Lancet Infectious Diseases. The journal offers the same unique fast track experience offered by its sister journals for all authors of research papers that are selected for peer review, where articles can be published online within 8 weeks of submission. The Lancet Respiratory Medicine is indexed in PubMed, and has been approved for indexing and abstracting in SciSearch®, Journal Citation Reports, and Current Contents® by Thomson Reuters

Metrics from SCImago Journal Rank 2025. View on SCImago